🔎 Trials Near Me

Home › Multiple Myeloma › California › Irvine

Pag-aaral pangklinika para sa Multiple Myeloma sa Irvine, CA

Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Irvine. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Nagre-recruitPhase 1
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07409246

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Nagre-recruitPhase 1
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05652335

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Nagre-recruitPhase 3
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05552222

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1/2
  • City of Hope - Lennar, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07336472

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

Nagre-recruitPhase 2
  • City of Hope at Irvine Lennar, Irvine
Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06052826

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 3
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07258511

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 3
  • UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07518186

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

Nagre-recruitPhase 3
  • City of Hope - Lennar Foundation Cancer Center, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07555938

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Nagre-recruitPhase 1/2
  • Research Site, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06106945

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Nagre-recruitPhase 1/2
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06892522

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Nagre-recruitPhase 4
  • UCI Health - Irvine Infusion Pharmacy ACC, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06057402

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • City of Hope at Irvine Lennar, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT07225738

Pag-aaral para sa Multiple Myeloma sa ibang lungsod

Iba pang pag-aaral sa Irvine

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.